Latest Breaking News On - European medicines agency tuesday - Page 1 : comparemela.com

According to the head of the European Medicines Agency Tuesday, health regulators remain firmly convinced that the benefits of Astrazeneca s COVID-19 vaccines outweigh the potential risks. While the investigation is ongoing, currently, we are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalization and death, outweigh the risks of these side effects. The remarks come as number of European countries have halted use of the AstraZeneca vaccine, amid concerns the shots caused blood clots in some recipients. However, the official shot down those concerns, saying there was no indication the vaccine caused such adverse side effects.

Lee seung jaeEuropean medicines agencyEuropean medicines agency tuesdayArirang tvArirang radioArirang newsலீ சீங் ஜேஅரிராங் தொலைக்காட்சிஅரிராங் வானொலிஅரிராங் செய்தி